Journal of Antimicrobial Chemotherapy · 2012 · 83 citations · 26 references
MedicineImmunologyPharmacologyAntimicrobial ResistanceInflammationInnate ImmunityAntibacterial AgentsAntibacterial PharmacologyAntimicrobial PeptidesAntimicrobial ToxicityAntibacterial PeptidesAntimicrobial Peptide ActivityBactericidal AgentsBioactive Peptide MimicsCationic Antimicrobial PeptidesGingival FibroblastsHost Antimicrobial PeptidesLactate Dehydrogenase Release Assays
OBJECTIVES: We aim to develop antibacterial peptide mimics resistant to protease degradation, with broad-spectrum activity at sites of infection. METHODS: The bactericidal activities of LL-37, ceragenins CSA-13, CSA-90 and CSA-92 and the spermine-conjugated dexamethasone derivative D2S were evaluated using MIC and MBC measurements. Gingival fibroblast counting, interleukin-8 (IL-8) and lactate dehydrogenase (LDH) release from keratinocytes (HaCat) were used to determine effects on cell growth, pro-inflammatory response and toxicity. RESULTS: All tested cationic lipids showed stronger bactericidal activity than LL-37. Incubation of Staphylococcus aureus with half the MIC of LL-37 led to the appearance of bacteria resistant to its bactericidal effects, but identical incubations with CSA-13 or D2S did not produce resistant bacteria. Cathelicidin LL-37 significantly increased the total number of gingival fibroblasts, but ceragenins and D2S did not alter gingival fibroblast growth. Cationic lipids showed no toxicity to HaCat cells at concentrations resulting in bacterial killing. CONCLUSIONS: These data suggest that cationic lipids such as ceragenins warrant further testing as potential novel antibacterial agents.
26
Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide
Roberto Lande, Josh Gregorio, Valeria Facchinetti et al. · Nature · 2007 · 1.9K citations
An angiogenic role for the human peptide antibiotic LL-37/hCAP-18
Georges von Degenfeld, Christian Kupatt, Florian Krötz et al. · Journal of Clinical Investigation · 2003 · 842 citations · Full text
Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein
James W. Larrick, Michimasa Hirata, Robert F. Balint et al. · Infection and Immunity · 1995 · 572 citations · Full text